To effectively treat a disease or disorder, doctors must first know the root cause. Such is the case for developmental and epileptic encephalopathies (DEEs), whose root causes can be hugely complex and heterogeneous. Scientists at St. Jude Children’s Research Hospital demonstrated the value of DNA methylation patterns for identifying the root cause of DEEs, showing specific gene methylation and genome-wide methylation “episignatures” can help identify the genes that cause DEE. The findings were published today in Nature Communications.
Gilead stops another CD47 study, this time in acute myeloid leukemia
Gilead stopped a Phase III study of its CD47 antibody magrolimab in patients who have acute myeloid leukemia with TP53 mutations, the company announced Tuesday.